LHX3
LIM/homeobox protein Lhx3
Also known as: LHX3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UBR4
- Gene
- LHX3
- Ensembl
- ENSG00000107187
- Chromosome
- 9
- Canonical length
- 397 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
This gene encodes a member of a large family of proteins which carry the LIM domain, a unique cysteine-rich zinc-binding domain. The encoded protein is a transcription factor that is required for pituitary development and motor neuron specification. Mutations in this gene cause combined pituitary hormone deficiency 3. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
Canonical amino-acid sequenceUniProt
397 residues, UniProt reviewed canonical sequence.
>Q9UBR4|LHX3
1 MLLETGLERD RARPGAAAVC TLGGTREIPL CAGCDQHILD RFILKALDRH WHSKCLKCSD
61 CHTPLAERCF SRGESVYCKD DFFKRFGTKC AACQLGIPPT QVVRRAQDFV YHLHCFACVV
121 CKRQLATGDE FYLMEDSRLV CKADYETAKQ REAEATAKRP RTTITAKQLE TLKSAYNTSP
181 KPARHVREQL SSETGLDMRV VQVWFQNRRA KEKRLKKDAG RQRWGQYFRN MKRSRGGSKS
241 DKDSVQEGQD SDAEVSFPDE PSLAEMGPAN GLYGSLGEPT QALGRPSGAL GNFSLEHGGL
301 AGPEQYRELR PGSPYGVPPS PAAPQSLPGP QPLLSSLVYP DTSLGLVPSG APGGPPPMRV
361 LAGNGPSSDL STGSSGGYPD FPASPASWLD EVDHAQFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LHX3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 49 nTPM
Expression across tissuesHPA
Tissue
- pituitary gland: 49 nTPM
- retina: 1 nTPM
- choroid plexus: 0.6 nTPM
- thymus: 0.4 nTPM
- cerebral cortex: 0.2 nTPM
- bone marrow: 0.1 nTPM
Single-cell type
- pituitary stem cells: 201 nCPM
- retinal bipolar cells: 22 nCPM
- lactotrophs: 18 nCPM
- thyrotrophs: 10 nCPM
- gonadotrophs: 5.6 nCPM
- somatotrophs: 3.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 2.1 nTPM
- medulla oblongata: 1 nTPM
- hypothalamus: 0.6 nTPM
- thalamus: 0.2 nTPM
- cerebral cortex: 0.1 nTPM
- choroid plexus: 0.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LHX3.
Disease | AllUniProt
Conditions LHX3 is implicated in, by any mechanism.
- Pituitary hormone deficiency, combined, 3 (CPHD3) MIM:221750
Disease | GeneticClinVar
51 pathogenic / likely-pathogenic of 642 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Non-acquired combined pituitary hormone deficiency with spine abnormalities
- Combined pituitary hormone deficiencies, genetic form
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.74
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.33
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- animal organ morphogenesis
- apoptotic process
- inner ear development
- lung development
- medial motor column neuron differentiation
- motor neuron axon guidance
- negative regulation of apoptotic process
- neuron differentiation
- placenta development
- positive regulation of DNA-templated transcription
- positive regulation of transcription by RNA polymerase II
- prolactin secreting cell differentiation
- regulation of transcription by RNA polymerase II
- somatotropin secreting cell differentiation
- spinal cord association neuron differentiation
- spinal cord motor neuron cell fate specification
- thyroid-stimulating hormone-secreting cell differentiation
- ventral spinal cord interneuron specification
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- sequence-specific DNA binding
- transcription coactivator binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LHX3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LHX3 as an antibody target. Whether an autoantibody or antibody against LHX3 could matter depends on whether native LHX3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LHX3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LHX3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...